市場調査レポート

商品コード

1611070

エクソソームの市場規模、シェア、動向分析レポート：製品・サービス別、ワークフロー別、最終用途別、地域別、セグメント別予測、2025年～2030年

Exosomes Market Size, Share & Trends Analysis Report By Product & Service (Kits & Reagents, Services), By Workflow (Isolation Methods, Downstream Analysis), By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030

出版日: 2024年11月18日
発行: Grand View Research
ページ情報: 英文 140 Pages
納期: 2～10営業日

カスタマイズ可能

価格

Unprintable PDF (Single User License)

USD 5,950 857,157円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストはできません。PDFの印刷もできません。

Printable PDF (5-User License)

USD 6,950 1,001,217円

レポートPDFを同一企業内の同一部署における5名様までの方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

Printable PDF (Enterprise License)

USD 8,950 1,289,337円

レポートPDFの購入企業、およびその子会社、関連会社の方にご使用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

エクソソーム市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界のエクソソーム市場規模は2030年までに7億9,420万米ドルに達すると推定され、2025～2030年にかけて28.73%のCAGRで成長すると予測しています。

市場を牽引する主要要因には、エクソソーム分離と分析手順の技術的進歩、エクソソーム研究のための政府と非政府イニシアチブの成長、がんの有病率の増加などがあります。例えば、世界保健機関（WHO）によると、2020年にはがんによる死亡者数は約1,000万人であり、がんは世界の主要な死因の1つとなっています。この産業は、がんバイオマーカーの同定、感染因子の検出、神経変性と心血管疾患（CVDs）の治療オプションの発見に対するニーズの高まりなどの要因により、急速な成長が見込まれています。

細胞から体液中に放出されるエクソソームは、健康な人と比較して、様々な疾患の患者において異なるRNA、タンパク質、脂質の含有量を示します。したがって、エクソソームは、バイオマーカー同定を用いた診断手順の開発に使用することができます。したがって、迅速で正確かつ低侵襲の診断手順に対する需要の高まりは、エクソソーム応用の成長機会として有望です。COVID-19のパンデミックは、2020年にエクソソームの診断と治療の可能性を調査する臨床検査の中断につながりました。さらに、全国的な封鎖規制、サプライチェーンの混乱、COVID-19関連製品への投資の流用により、エクソソームに関わる研究開発活動は減少しました。

2020年の悪影響にもかかわらず、このパンデミックは、エクソソームを利用したCOVID-19ワクチンや治療の開発にいくつかの新たな展望を開き、その結果、今後数年間の産業の成長を押し上げると期待されています。例えば、2021年3月、米国を拠点とするバイオテクノロジー研究機関であるCell Guidance Systemsは、COVID-19疾患を治療するためのエクソソーム治療の開発計画を発表しました。さらに、エクソソーム研究のための政府と非政府イニシアチブの成長は、調査期間中の成長を促進すると考えられます。例えば、2023年1月、Mantra Bioは、リード対象を持つエクソソーム治療プログラムの開発を進めるために900万米ドルの資金を調達しました。

同様に、2021年2月、Evox Therapeuticsは、エクソソーム治療を前進させ、同社の主要エクソームプラットフォームDeliverEXを世界的に拡大するために9,518万米ドルの資金を調達しました。しかし、エクソソーム製品の承認と商業化に関する厳しい規制が、予測期間中の産業の成長を妨げる可能性があります。また、エクソソームの様々な用途への導入に伴う技術的な困難が、調査期間中の成長を妨げる可能性があります。主要課題には、効率的なトランスフェクション戦略の欠如や精製方法の最適化の必要性などがあります。このような課題は、市場の成長を阻害すると予想されます。

エクソソーム市場レポートハイライト

キットと試薬セグメントが2024年に最大の収益シェアを占めました。細胞外小胞の単離は難しく、非特異的で、面倒なプロセスです。それゆえ、主要企業はエキソソームの用途を広げるために革新的なキットや試薬を発売しており、これがセグメントの成長を促進しています。
ワークフロー別では、下流分析セグメントが2024年に最大のシェアを占めました。主要企業は、下流分析の有用性を高めるためにさまざまな技術的に先進的製品を提供しており、これはセグメントの成長にプラスの影響を与える可能性があります。
がんの診断、予後、治療におけるエクソソームの応用範囲が広いため、がん用途セグメントが2024年の市場を独占しました。
2023年には、研究開発活動の増加により、製薬・バイオテクノロジー企業の最終用途が産業をリードしました。
北米は、主要参入企業の存在、新しいバイオマーカーの検出に対する政府資金の増加、慢性疾患の高い発生率により、2024年に支配的な地域でした。

セグメントダッシュボード
世界エクソソーム市場のワークフロー変動分析
世界のエクソソーム市場規模と動向分析、ワークフロー別、2018～2030年
隔離方法
- 超遠心分離
- ビーズ上の免疫捕捉
- 降水量
- 濾過
- その他
下流分析
- フローサイトメトリーを用いた細胞表面マーカー分析
- ブロッティングとELISAを使用したタンパク質分析
- NGSとPCRによるRNA分析
- 質量分析法を用いたプロテオーム分析
- その他

第6章エキソソーム市場：用途別、推定・動向分析

セグメントダッシュボード
世界のエクソソーム市場の用途変動分析
世界のエクソソーム市場規模と動向分析、用途別、2018～2030年
がん
神経変性疾患
心血管疾患
感染症
その他

第7章エキソソーム市場：最終用途別、推定・動向分析

セグメントダッシュボード
世界のエクソソーム市場の最終用途変動分析
世界のエクソソーム市場規模と動向分析、最終用途別、2018～2030年
製薬・バイオテクノロジー企業
病院と診断センター
学術研究機関

第8章エキソソーム市場：地域別、推定・動向分析

地域別市場シェア分析、2024年と2030年
地域別市場ダッシュボード
市場規模、予測動向分析、2018～2030年
北米
- 米国
- カナダ
- メキシコ
欧州
- 英国
- ドイツ
- フランス
- イタリア
- スペイン
- ノルウェー
- スウェーデン
- デンマーク
アジア太平洋
- 日本
- 中国
- インド
- オーストラリア
- 韓国
- タイ
- シンガポール
ラテンアメリカ
- ブラジル
- アルゼンチン
中東・アフリカ
- 南アフリカ
- サウジアラビア
- アラブ首長国連邦
- クウェート

第9章競合情勢

企業/競合の分類
戦略マッピング
企業市況分析、2024年
企業プロファイル/上場企業
- Bio-Techne
- Danaher
- Hologic Inc.
- Fujifilm Holdings Corporation
- Lonza
- Miltenyi BIoTec
- Qiagen
- Thermo Fisher Scientific, Inc.
- Abcam Plc
- RoosterBio, Inc.

図表

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global exosomes market, by product & service, 2018 - 2030 (USD Million)
Table 4 Global exosomes market, by workflow, 2018 - 2030 (USD Million)
Table 5 Global exosomes market, by application, 2018 - 2030 (USD Million)
Table 6 Global exosomes market, by end use, 2018 - 2030 (USD Million)
Table 7 Global exosomes market, by region, 2018 - 2030 (USD Million)
Table 8 North America exosomes market, by country, 2018 - 2030 (USD Million)
Table 9 North America exosomes market, by product & service, 2018 - 2030 (USD Million)
Table 10 North America exosomes market, by workflow, 2018 - 2030 (USD Million)
Table 11 North America exosomes market, by application, 2018 - 2030 (USD Million)
Table 12 North America exosomes market, by end use, 2018 - 2030 (USD Million)
Table 13 U.S. exosomes market, by product & service, 2018 - 2030 (USD Million)
Table 14 U.S. exosomes market, by workflow, 2018 - 2030 (USD Million)
Table 15 U.S. exosomes market, by application, 2018 - 2030 (USD Million)
Table 16 U.S. exosomes market, by end use, 2018 - 2030 (USD Million)
Table 17 Canada exosomes market, by product & service, 2018 - 2030 (USD Million)
Table 18 Canada exosomes market, by workflow, 2018 - 2030 (USD Million)
Table 19 Canada exosomes market, by application, 2018 - 2030 (USD Million)
Table 20 Canada exosomes market, by end use, 2018 - 2030 (USD Million)
Table 21 Mexico exosomes market, by product & service, 2018 - 2030 (USD Million)
Table 22 Mexico exosomes market, by workflow, 2018 - 2030 (USD Million)
Table 23 Mexico exosomes market, by application, 2018 - 2030 (USD Million)
Table 24 Mexico exosomes market, by end use, 2018 - 2030 (USD Million)
Table 25 Europe exosomes market, by country, 2018 - 2030 (USD Million)
Table 26 Europe exosomes market, by product & service, 2018 - 2030 (USD Million)
Table 27 Europe exosomes market, by workflow, 2018 - 2030 (USD Million)
Table 28 Europe exosomes market, by application, 2018 - 2030 (USD Million)
Table 29 Europe exosomes market, by end use, 2018 - 2030 (USD Million)
Table 30 UK exosomes market, by product & service, 2018 - 2030 (USD Million)
Table 31 UK exosomes market, by workflow, 2018 - 2030 (USD Million)
Table 32 UK exosomes market, by application, 2018 - 2030 (USD Million)
Table 33 UK exosomes market, by end use, 2018 - 2030 (USD Million)
Table 34 Germany exosomes market, by product & service, 2018 - 2030 (USD Million)
Table 35 Germany exosomes market, by workflow, 2018 - 2030 (USD Million)
Table 36 Germany exosomes market, by application, 2018 - 2030 (USD Million)
Table 37 Germany exosomes market, by end use, 2018 - 2030 (USD Million)
Table 38 France exosomes market, by product & service, 2018 - 2030 (USD Million)
Table 39 France exosomes market, by workflow, 2018 - 2030 (USD Million)
Table 40 France exosomes market, by application, 2018 - 2030 (USD Million)
Table 41 France exosomes market, by end use, 2018 - 2030 (USD Million)
Table 42 Italy exosomes market, by product & service, 2018 - 2030 (USD Million)
Table 43 Italy exosomes market, by workflow, 2018 - 2030 (USD Million)
Table 44 Italy exosomes market, by application, 2018 - 2030 (USD Million)
Table 45 Italy exosomes market, by end use, 2018 - 2030 (USD Million)
Table 46 Spain exosomes market, by product & service, 2018 - 2030 (USD Million)
Table 47 Spain exosomes market, by workflow, 2018 - 2030 (USD Million)
Table 48 Spain exosomes market, by application, 2018 - 2030 (USD Million)
Table 49 Spain exosomes market, by end use, 2018 - 2030 (USD Million)
Table 50 Denmark exosomes market, by product & service, 2018 - 2030 (USD Million)
Table 51 Denmark exosomes market, by workflow, 2018 - 2030 (USD Million)
Table 52 Denmark exosomes market, by application, 2018 - 2030 (USD Million)
Table 53 Denmark exosomes market, by end use, 2018 - 2030 (USD Million)
Table 54 Sweden exosomes market, by product & service, 2018 - 2030 (USD Million)
Table 55 Sweden exosomes market, by workflow, 2018 - 2030 (USD Million)
Table 56 Sweden exosomes market, by application, 2018 - 2030 (USD Million)
Table 57 Sweden exosomes market, by end use, 2018 - 2030 (USD Million)
Table 58 Norway exosomes market, by product & service, 2018 - 2030 (USD Million)
Table 59 Norway exosomes market, by workflow, 2018 - 2030 (USD Million)
Table 60 Norway exosomes market, by application, 2018 - 2030 (USD Million)
Table 61 Norway exosomes market, by end use, 2018 - 2030 (USD Million)
Table 62 Asia Pacific exosomes market, by country, 2018 - 2030 (USD Million)
Table 63 Asia Pacific exosomes market, by product & service, 2018 - 2030 (USD Million)
Table 64 Asia Pacific exosomes market, by workflow, 2018 - 2030 (USD Million)
Table 65 Asia Pacific exosomes market, by application, 2018 - 2030 (USD Million)
Table 66 Asia Pacific exosomes market, by end use, 2018 - 2030 (USD Million)
Table 67 Japan exosomes market, by product & service, 2018 - 2030 (USD Million)
Table 68 Japan exosomes market, by workflow, 2018 - 2030 (USD Million)
Table 69 Japan exosomes market, by application, 2018 - 2030 (USD Million)
Table 70 Japan exosomes market, by end use, 2018 - 2030 (USD Million)
Table 71 China exosomes market, by product & service, 2018 - 2030 (USD Million)
Table 72 China exosomes market, by workflow, 2018 - 2030 (USD Million)
Table 73 China exosomes market, by application, 2018 - 2030 (USD Million)
Table 74 China exosomes market, by end use, 2018 - 2030 (USD Million)
Table 75 India exosomes market, by product & service, 2018 - 2030 (USD Million)
Table 76 India exosomes market, by workflow, 2018 - 2030 (USD Million)
Table 77 India exosomes market, by application, 2018 - 2030 (USD Million)
Table 78 India exosomes market, by end use, 2018 - 2030 (USD Million)
Table 79 Australia exosomes market, by product & service, 2018 - 2030 (USD Million)
Table 80 Australia exosomes market, by workflow, 2018 - 2030 (USD Million)
Table 81 Australia exosomes market, by application, 2018 - 2030 (USD Million)
Table 82 Australia exosomes market, by end use, 2018 - 2030 (USD Million)
Table 83 Thailand exosomes market, by product & service, 2018 - 2030 (USD Million)
Table 84 Thailand exosomes market, by workflow, 2018 - 2030 (USD Million)
Table 85 Thailand exosomes market, by application, 2018 - 2030 (USD Million)
Table 86 Thailand exosomes market, by end use, 2018 - 2030 (USD Million)
Table 87 South Korea exosomes market, by product & service, 2018 - 2030 (USD Million)
Table 88 South Korea exosomes market, by workflow, 2018 - 2030 (USD Million)
Table 89 South Korea exosomes market, by application, 2018 - 2030 (USD Million)
Table 90 South Korea exosomes market, by end use, 2018 - 2030 (USD Million)
Table 91 Singapore exosomes market, by product & service, 2018 - 2030 (USD Million)
Table 92 Singapore exosomes market, by workflow, 2018 - 2030 (USD Million)
Table 93 Singapore exosomes market, by application, 2018 - 2030 (USD Million)
Table 94 Singapore exosomes market, by end use, 2018 - 2030 (USD Million)
Table 95 Latin America exosomes market, by country, 2018 - 2030 (USD Million)
Table 96 Latin America exosomes market, by product & service, 2018 - 2030 (USD Million)
Table 97 Latin America exosomes market, by workflow, 2018 - 2030 (USD Million)
Table 98 Latin America exosomes market, by application, 2018 - 2030 (USD Million)
Table 99 Latin America exosomes market, by end use, 2018 - 2030 (USD Million)
Table 100 Brazil exosomes market, by product & service, 2018 - 2030 (USD Million)
Table 101 Brazil exosomes market, by workflow, 2018 - 2030 (USD Million)
Table 102 Brazil exosomes market, by application, 2018 - 2030 (USD Million)
Table 103 Brazil exosomes market, by end use, 2018 - 2030 (USD Million)
Table 104 Argentina exosomes market, by product & service, 2018 - 2030 (USD Million)
Table 105 Argentina exosomes market, by workflow, 2018 - 2030 (USD Million)
Table 106 Argentina exosomes market, by application, 2018 - 2030 (USD Million)
Table 107 Argentina exosomes market, by end use, 2018 - 2030 (USD Million)
Table 108 Middle East & Africa exosomes market, by country, 2018 - 2030 (USD Million)
Table 109 Middle East & Africa exosomes market, by product & service, 2018 - 2030 (USD Million)
Table 110 Middle East & Africa exosomes market, by workflow, 2018 - 2030 (USD Million)
Table 111 Middle East & Africa exosomes market, by application, 2018 - 2030 (USD Million)
Table 112 Middle East & Africa exosomes market, by end use, 2018 - 2030 (USD Million)
Table 113 South Africa exosomes market, by product & service, 2018 - 2030 (USD Million)
Table 114 South Africa exosomes market, by workflow, 2018 - 2030 (USD Million)
Table 115 South Africa exosomes market, by application, 2018 - 2030 (USD Million)
Table 116 South Africa exosomes market, by end use, 2018 - 2030 (USD Million)
Table 117 Saudi Arabia exosomes market, by product & service, 2018 - 2030 (USD Million)
Table 118 Saudi Arabia exosomes market, by workflow, 2018 - 2030 (USD Million)
Table 119 Saudi Arabia exosomes market, by application, 2018 - 2030 (USD Million)
Table 120 Saudi Arabia exosomes market, by end use, 2018 - 2030 (USD Million)
Table 121 UAE exosomes market, by product & service, 2018 - 2030 (USD Million)
Table 122 UAE exosomes market, by workflow, 2018 - 2030 (USD Million)
Table 123 UAE exosomes market, by application, 2018 - 2030 (USD Million)
Table 124 UAE exosomes market, by end use, 2018 - 2030 (USD Million)
Table 125 Kuwait exosomes market, by product & service, 2018 - 2030 (USD Million)
Table 126 Kuwait exosomes market, by workflow, 2018 - 2030 (USD Million)
Table 127 Kuwait exosomes market, by application, 2018 - 2030 (USD Million)
Table 128 Kuwait exosomes market, by end use, 2018 - 2030 (USD Million)
Table 129 Participant's overview
Table 130 Financial performance
Table 131 Key companies undergoing acquisitions
Table 132 Key companies undergoing collaborations & partnerships
Table 133 Key companies launching new products/services
Table 134 Key companies undertaking other strategies

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market outlook
Fig. 9 Market segment snapshot
Fig. 10 Competitive landscape snapshot
Fig. 11 Market driver impact
Fig. 12 Market restraint impact
Fig. 13 Porter's analysis
Fig. 14 PESTEL analysis
Fig. 15 Exosome market: Product & service outlook and key takeaways
Fig. 16 Exosome market: Product & service movement analysis
Fig. 17 Global kits & reagents market, 2018 - 2030 (USD Million)
Fig. 18 Global instruments market, 2018 - 2030 (USD Million)
Fig. 19 Global services market, 2018 - 2030 (USD Million)
Fig. 20 Exosome market: Workflow outlook and key takeaways
Fig. 21 Exosome market: Workflow movement analysis
Fig. 22 Global isolation methods market, 2018 - 2030 (USD Million)
Fig. 23 Global ultracentrifugation market, 2018 - 2030 (USD Million)
Fig. 24 Global immunocapture on beads market, 2018 - 2030 (USD Million)
Fig. 25 Global precipitation market, 2018 - 2030 (USD Million)
Fig. 26 Global filtration market, 2018 - 2030 (USD Million)
Fig. 27 Global other isolation methods market, 2018 - 2030 (USD Million)
Fig. 28 Global downstream analysis market, 2018 - 2030 (USD Million)
Fig. 29 Global cell surface marker analysis using flow cytometry market, 2018 - 2030 (USD Million)
Fig. 30 Global protein analysis using blotting & ELISA market, 2018 - 2030 (USD Million)
Fig. 31 Global RNA analysis with NGS & PCR market, 2018 - 2030 (USD Million)
Fig. 32 Global proteomic analysis using mass spectroscopy market, 2018 - 2030 (USD Million)
Fig. 33 Global other downstream analysis market, 2018 - 2030 (USD Million)
Fig. 34 Exosome market: Application outlook and key takeaways
Fig. 35 Exosome market: Application movement analysis
Fig. 36 Global cancer market, 2018 - 2030 (USD Million)
Fig. 37 Global neurodegenerative diseases market, 2018 - 2030 (USD Million)
Fig. 38 Global cardiovascular diseases market, 2018 - 2030 (USD Million)
Fig. 39 Global infectious diseases market, 2018 - 2030 (USD Million)
Fig. 40 Global other applications market, 2018 - 2030 (USD Million)
Fig. 41 Exosome market: End Use outlook and key takeaways
Fig. 42 Exosome market: End Use movement analysis
Fig. 43 Global pharmaceutical & biotechnology companies market, 2018 - 2030 (USD Million)
Fig. 44 Global hospitals & diagnostics centers market, 2018 - 2030 (USD Million)
Fig. 45 Global academic & research institutes market, 2018 - 2030 (USD Million)
Fig. 46 Exosome market: Regional outlook and key takeaways
Fig. 47 North America exosome market, 2018 - 2030 (USD Million)
Fig. 48 U.S. key country dynamics
Fig. 49 U.S. exosome market, 2018 - 2030 (USD Million)
Fig. 50 Canada key country dynamics
Fig. 51 Canada exosome market, 2018 - 2030 (USD Million)
Fig. 52 Mexico key country dynamics
Fig. 53 Mexico exosome market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 54 Europe exosome market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 55 UK key country dynamics
Fig. 56 UK exosome market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 57 Germany key country dynamics
Fig. 58 Germany exosome market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 59 France key country dynamics
Fig. 60 France exosome market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 61 Italy key country dynamics
Fig. 62 Italy exosome market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 63 Spain key country dynamics
Fig. 64 Spain exosome market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 65 Denmark key country dynamics
Fig. 66 Denmark exosome market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 67 Sweden key country dynamics
Fig. 68 Sweden exosome market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 69 Norway key country dynamics
Fig. 70 Norway exosome market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 71 Asia-Pacific exosome market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 72 Japan key country dynamics
Fig. 73 Japan exosome market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 74 China key country dynamics
Fig. 75 China exosome market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 76 India key country dynamics
Fig. 77 India exosome market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 78 Australia key country dynamics
Fig. 79 Australia exosome market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 80 Thailand key country dynamics
Fig. 81 Thailand exosome market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 82 South Korea key country dynamics
Fig. 83 South Korea exosome market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 84 Singapore key country dynamics
Fig. 85 Singapore exosome market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 86 Latin America exosome market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 87 Brazil key country dynamics
Fig. 88 Brazil exosome market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 89 Argentina key country dynamics
Fig. 90 Argentina exosome market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 91 MEA exosome market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 92 South Africa key country dynamics
Fig. 93 South Africa exosome market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 94 Saudi Arabia key country dynamics
Fig. 95 Saudi Arabia exosome market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 96 UAE key country dynamics
Fig. 97 UAE exosome market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 98 Kuwait key country dynamics
Fig. 99 Kuwait exosome market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 100 Market participant categorization
Fig. 101 Exosomes market position analysis, 2024
Fig. 102 Strategy framework

Product Code: GVR-2-68038-298-3

Exosomes Market Growth & Trends:

The global exosomes market size is estimated to reach USD 794.2 million by 2030, registering to grow at a CAGR of 28.73% from 2025 to 2030 according to a new report by Grand View Research, Inc. The major factors driving the market include technological advancements in exosome isolation and analytical procedures, growth in government and non-government initiatives for exosome research, and the increasing prevalence of cancer. For instance, according to the World Health Organization (WHO), in 2020 there were about 10 million deaths due to cancer, making it one of the foremost causes of death worldwide. The industry is anticipated to witness rapid growth, owing to the factors, such as the growing need for the identification of cancer biomarkers, detection of infectious agents, and discovery of treatment options for neurodegenerative & Cardiovascular Diseases (CVDs).

Exosomes released by cells into body fluids display different RNA, protein, and lipid contents in patients with various disease conditions as compared to healthy individuals. Hence, exosomes can be used for the development of diagnostic procedures using biomarker identification. The rising demand for fast, accurate, and minimally invasive diagnostic procedures, thus, represents a promising opportunity for the growth of exosome applications. The COVID-19 pandemic led to the disruption of clinical trials investigating the diagnostic and therapeutic potential of exosomes in 2020. In addition, nationwide lockdown restrictions, disruption of supply chains, and diversion of investments toward COVID-19-related products led to a decrease in the research and development activities involving exosomes.

Despite the adverse impact in 2020, the pandemic has opened up several new prospects for the development of COVID-19 vaccines and treatments with the use of exosomes, which, in turn, is expected to boost industry growth over the coming years. For instance, in March 2021, Cell Guidance Systems, a U.S.-based biotechnology research organization, announced plans for the development of exosome therapeutics for treating COVID-19 disease. Moreover, growth in government and non-government initiatives for exosome research is likely to drive the growth during the study period. For instance, in Jan 2023, Mantra Bio raised funding of USD 9 million to advance the development of its lead-targeted exosome therapeutics program.

Similarly, in February 2021, Evox Therapeutics raised a funding of USD 95.18 million to advance the exosome therapeutics and expand the company's leading exome platform DeliverEX globally. However, stringent regulations pertaining to the approval and commercialization of exosome products may hamper the growth of the industry over the forecast period. In addition, technical difficulties associated with the implementation of exosomes in various applications may hamper the growth during the study period. Some of the major challenges include the lack of efficient transfection strategies and the need for optimization of purification methods. Such, challenges are anticipated to impede the market growth.

Exosomes Market Report Highlights:

The kits & reagents segment held the largest revenue share in 2024. Isolation of extracellular vesicles can be difficult, non-specific, and a tedious process. Hence, key players are launching innovative kits and reagents to broaden the applications of exosomes, which is fueling the segment growth
By workflow, the downstream analysis segment accounted for the largest share in 2024. Major players are offering various technologically advanced products for increasing the utility of downstream analyses, which can positively affect the segment growth
The cancer application segment dominated the market in 2024 due to the broad range of applications of exosomes in cancer diagnosis, prognosis, and treatment
The pharmaceutical & biotechnology companies end-use led industry in 2023 due to a rise in the R&D activities
North America was the dominant region in 2024 due to the presence of key players, rising government funding for the detection of new biomarkers, and high incidence of chronic conditions

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Market Definitions
- 1.2.1. Product & Service Segment
- 1.2.2. Workflow Segment
- 1.2.3. Application Segment
- 1.2.4. End Use Segment
1.3. Information analysis
- 1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
- 1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape

Chapter 3. Exosomes Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
- 3.2.1. Market driver analysis
  - 3.2.1.1. Technological advancements in exosomes isolation and analytical procedures
  - 3.2.1.2. Advanced applications of exosomes
  - 3.2.1.3. Growth in government and non-government initiatives for exosome research
  - 3.2.1.4. Increasing prevalence of cancer
- 3.2.2. Market restraint analysis
  - 3.2.2.1. Stringent regulations pertaining to approval
  - 3.2.2.2. Challenges associated with implementation of exosome-based therapies
3.3. Exosomes Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.2. PESTEL Analysis
- 3.3.3. COVID-19 Impact Analysis

Chapter 4. Exosomes Market: Product & Service Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Global Exosomes Market Product & Service Movement Analysis
4.3. Global Exosomes Market Size & Trend Analysis, by Product & Service, 2018 to 2030 (USD Million)
4.4. Kits & reagents
- 4.4.1. Kits & reagents market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Instruments
- 4.5.1. Instruments market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Services
- 4.6.1. Services market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Exosomes Market: Workflow Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Global Exosomes Market Workflow Movement Analysis
5.3. Global Exosomes Market Size & Trend Analysis, by Workflow, 2018 to 2030 (USD Million)
5.4. Isolation Methods
- 5.4.1. Isolation methods market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.2. Ultracentrifugation
  - 5.4.2.1. Ultracentrifugation market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.3. Immunocapture on beads
  - 5.4.3.1. Immunocapture on beads market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.4. Precipitation
  - 5.4.4.1. Precipitation market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.5. Filtration
  - 5.4.5.1. Filtration market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.6. Others
  - 5.4.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Downstream Analysis
- 5.5.1. Downstream analysis market estimates and forecasts 2018 to 2030 (USD Million)
- 5.5.2. Cell surface marker analysis using flow cytometry
  - 5.5.2.1. Cell surface marker analysis using flow cytometry market estimates and forecasts 2018 to 2030 (USD Million)
- 5.5.3. Protein Analysis using blotting & ELISA
  - 5.5.3.1. Protein Analysis using blotting & ELISA market estimates and forecasts 2018 to 2030 (USD Million)
- 5.5.4. RNA analysis with NGS & PCR
  - 5.5.4.1. RNA analysis with NGS & PCR market estimates and forecasts 2018 to 2030 (USD Million)
- 5.5.5. Proteomic analysis using mass spectroscopy
  - 5.5.5.1. Proteomic analysis using mass spectroscopy market estimates and forecasts 2018 to 2030 (USD Million)
- 5.5.6. Others
  - 5.5.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Exosomes Market: Application Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. Global Exosomes Market Application Movement Analysis
6.3. Global Exosomes Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
6.4. Cancer
- 6.4.1. Cancer market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Neurodegenerative Diseases
- 6.5.1. Neurodegenerative diseases market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Cardiovascular Diseases
- 6.6.1. Cardiovascular diseases market estimates and forecasts 2018 to 2030 (USD Million)
6.7. Infectious Diseases
- 6.7.1. Infectious diseases market estimates and forecasts 2018 to 2030 (USD Million)
6.8. Others
- 6.8.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Exosomes Market: End Use Estimates & Trend Analysis

7.1. Segment Dashboard
7.2. Global Exosomes Market End Use Movement Analysis
7.3. Global Exosomes Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
7.4. Pharmaceutical & Biotechnology Companies
- 7.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Hospitals & Diagnostics Centers
- 7.5.1. Hospitals & diagnostics centers market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Academic & Research Institutes
- 7.6.1. Academic & research institutes market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Exosomes Market: Regional Estimates & Trend Analysis

8.1. Regional Market Share Analysis, 2024 & 2030
8.2. Regional Market Dashboard
8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
8.4. North America
- 8.4.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
- 8.4.2. U.S.
  - 8.4.2.1. Key country dynamics
  - 8.4.2.2. Competitive scenario
  - 8.4.2.3. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
- 8.4.3. Canada
  - 8.4.3.1. Key country dynamics
  - 8.4.3.2. Competitive scenario
  - 8.4.3.3. Canada market estimates and forecasts 2018 to 2030 (USD Million)
- 8.4.4. Mexico
  - 8.4.4.1. Key country dynamics
  - 8.4.4.2. Competitive scenario
  - 8.4.4.3. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
8.5. Europe
- 8.5.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
- 8.5.2. UK
  - 8.5.2.1. Key country dynamics
  - 8.5.2.2. Competitive scenario
  - 8.5.2.3. UK market estimates and forecasts 2018 to 2030 (USD Million)
- 8.5.3. Germany
  - 8.5.3.1. Key country dynamics
  - 8.5.3.2. Competitive scenario
  - 8.5.3.3. Germany market estimates and forecasts 2018 to 2030 (USD Million)
- 8.5.4. France
  - 8.5.4.1. Key country dynamics
  - 8.5.4.2. Competitive scenario
  - 8.5.4.3. France market estimates and forecasts 2018 to 2030 (USD Million)
- 8.5.5. Italy
  - 8.5.5.1. Key country dynamics
  - 8.5.5.2. Competitive scenario
  - 8.5.5.3. Italy market estimates and forecasts 2018 to 2030 (USD Million)
- 8.5.6. Spain
  - 8.5.6.1. Key country dynamics
  - 8.5.6.2. Competitive scenario
  - 8.5.6.3. Spain market estimates and forecasts 2018 to 2030 (USD Million)
- 8.5.7. Norway
  - 8.5.7.1. Key country dynamics
  - 8.5.7.2. Competitive scenario
  - 8.5.7.3. Norway market estimates and forecasts 2018 to 2030 (USD Million)
- 8.5.8. Sweden
  - 8.5.8.1. Key country dynamics
  - 8.5.8.2. Competitive scenario
  - 8.5.8.3. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
- 8.5.9. Denmark
  - 8.5.9.1. Key country dynamics
  - 8.5.9.2. Competitive scenario
  - 8.5.9.3. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
8.6. Asia Pacific
- 8.6.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.2. Japan
  - 8.6.2.1. Key country dynamics
  - 8.6.2.2. Competitive scenario
  - 8.6.2.3. Japan market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.3. China
  - 8.6.3.1. Key country dynamics
  - 8.6.3.2. Competitive scenario
  - 8.6.3.3. China market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.4. India
  - 8.6.4.1. Key country dynamics
  - 8.6.4.2. Competitive scenario
  - 8.6.4.3. India market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.5. Australia
  - 8.6.5.1. Key country dynamics
  - 8.6.5.2. Competitive scenario
  - 8.6.5.3. Australia market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.6. South Korea
  - 8.6.6.1. Key country dynamics
  - 8.6.6.2. Competitive scenario
  - 8.6.6.3. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.7. Thailand
  - 8.6.7.1. Key country dynamics
  - 8.6.7.2. Competitive scenario
  - 8.6.7.3. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.8. Singapore
  - 8.6.8.1. Key country dynamics
  - 8.6.8.2. Competitive scenario
  - 8.6.8.3. Singapore market estimates and forecasts 2018 to 2030 (USD Million)
8.7. Latin America
- 8.7.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
- 8.7.2. Brazil
  - 8.7.2.1. Key country dynamics
  - 8.7.2.2. Competitive scenario
  - 8.7.2.3. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
- 8.7.3. Argentina
  - 8.7.3.1. Key country dynamics
  - 8.7.3.2. Competitive scenario
  - 8.7.3.3. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
8.8. MEA
- 8.8.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
- 8.8.2. South Africa
  - 8.8.2.1. Key country dynamics
  - 8.8.2.2. Competitive scenario
  - 8.8.2.3. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
- 8.8.3. Saudi Arabia
  - 8.8.3.1. Key country dynamics
  - 8.8.3.2. Competitive scenario
  - 8.8.3.3. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
- 8.8.4. UAE
  - 8.8.4.1. Key country dynamics
  - 8.8.4.2. Competitive scenario
  - 8.8.4.3. UAE market estimates and forecasts 2018 to 2030 (USD Million)
- 8.8.5. Kuwait
  - 8.8.5.1. Key country dynamics
  - 8.8.5.2. Competitive scenario
  - 8.8.5.3. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

9.1. Company/Competition Categorization
9.2. Strategy Mapping
9.3. Company Market Position Analysis, 2024
9.4. Company Profiles/Listing
- 9.4.1. Bio-Techne
  - 9.4.1.1. Company overview
  - 9.4.1.2. Financial performance
  - 9.4.1.3. Product/Service benchmarking
  - 9.4.1.4. Strategic initiatives
- 9.4.2. Danaher
  - 9.4.2.1. Company overview
  - 9.4.2.2. Financial performance
  - 9.4.2.3. Product/Service benchmarking
  - 9.4.2.4. Strategic initiatives
- 9.4.3. Hologic Inc.
  - 9.4.3.1. Company overview
  - 9.4.3.2. Financial performance
  - 9.4.3.3. Product/Service benchmarking
  - 9.4.3.4. Strategic initiatives
- 9.4.4. Fujifilm Holdings Corporation
  - 9.4.4.1. Company overview
  - 9.4.4.2. Financial performance
  - 9.4.4.3. Product/Service benchmarking
  - 9.4.4.4. Strategic initiatives
- 9.4.5. Lonza
  - 9.4.5.1. Company overview
  - 9.4.5.2. Financial performance
  - 9.4.5.3. Product/Service benchmarking
  - 9.4.5.4. Strategic initiatives
- 9.4.6. Miltenyi Biotec
  - 9.4.6.1. Company overview
  - 9.4.6.2. Financial performance
  - 9.4.6.3. Product/Service benchmarking
  - 9.4.6.4. Strategic initiatives
- 9.4.7. Qiagen
  - 9.4.7.1. Company overview
  - 9.4.7.2. Financial performance
  - 9.4.7.3. Product/Service benchmarking
  - 9.4.7.4. Strategic initiatives
- 9.4.8. Thermo Fisher Scientific, Inc.
  - 9.4.8.1. Company overview
  - 9.4.8.2. Financial performance
  - 9.4.8.3. Product/Service benchmarking
  - 9.4.8.4. Strategic initiatives
- 9.4.9. Abcam Plc
  - 9.4.9.1. Company overview
  - 9.4.9.2. Financial performance
  - 9.4.9.3. Product/Service benchmarking
  - 9.4.9.4. Strategic initiatives
- 9.4.10. RoosterBio, Inc.
  - 9.4.10.1. Company overview
  - 9.4.10.2. Financial performance
  - 9.4.10.3. Product/Service benchmarking
  - 9.4.10.4. Strategic initiatives

エクソソームの市場規模、シェア、動向分析レポート：製品・サービス別、ワークフロー別、最終用途別、地域別、セグメント別予測、2025年～2030年

Exosomes Market Size, Share & Trends Analysis Report By Product & Service (Kits & Reagents, Services), By Workflow (Isolation Methods, Downstream Analysis), By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030

エクソソーム市場の成長と動向

エクソソーム市場レポートハイライト

目次

第1章調査手法と範囲

第2章エグゼクティブサマリー

第3章エキソソーム市場の変数、動向、範囲

第4章エキソソーム市場：製品とサービス別、推定・動向分析

第5章エキソソーム市場：ワークフロー別、推定・動向分析

第6章エキソソーム市場：用途別、推定・動向分析

第7章エキソソーム市場：最終用途別、推定・動向分析

第8章エキソソーム市場：地域別、推定・動向分析

第9章競合情勢

List of Tables

List of Figures

Exosomes Market Growth & Trends:

Exosomes Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Exosomes Market Variables, Trends & Scope

Chapter 4. Exosomes Market: Product & Service Estimates & Trend Analysis

Chapter 5. Exosomes Market: Workflow Estimates & Trend Analysis

Chapter 6. Exosomes Market: Application Estimates & Trend Analysis

Chapter 7. Exosomes Market: End Use Estimates & Trend Analysis

Chapter 8. Exosomes Market: Regional Estimates & Trend Analysis

Chapter 9. Competitive Landscape

エクソソームの市場規模、シェア、動向分析レポート：製品・サービス別、ワークフロー別、最終用途別、地域別、セグメント別予測、2025年～2030年

Exosomes Market Size, Share & Trends Analysis Report By Product & Service (Kits & Reagents, Services), By Workflow (Isolation Methods, Downstream Analysis), By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030

エクソソーム市場の成長と動向

エクソソーム市場レポートハイライト

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 エキソソーム市場の変数、動向、範囲

第4章 エキソソーム市場：製品とサービス別、推定・動向分析

第5章 エキソソーム市場：ワークフロー別、推定・動向分析

第6章 エキソソーム市場：用途別、推定・動向分析

第7章 エキソソーム市場：最終用途別、推定・動向分析

第8章 エキソソーム市場：地域別、推定・動向分析

第9章 競合情勢

List of Tables

List of Figures

Exosomes Market Growth & Trends:

Exosomes Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Exosomes Market Variables, Trends & Scope

Chapter 4. Exosomes Market: Product & Service Estimates & Trend Analysis

Chapter 5. Exosomes Market: Workflow Estimates & Trend Analysis

Chapter 6. Exosomes Market: Application Estimates & Trend Analysis

Chapter 7. Exosomes Market: End Use Estimates & Trend Analysis

Chapter 8. Exosomes Market: Regional Estimates & Trend Analysis

Chapter 9. Competitive Landscape

第1章調査手法と範囲

第2章エグゼクティブサマリー

第3章エキソソーム市場の変数、動向、範囲

第4章エキソソーム市場：製品とサービス別、推定・動向分析

第5章エキソソーム市場：ワークフロー別、推定・動向分析

第6章エキソソーム市場：用途別、推定・動向分析

第7章エキソソーム市場：最終用途別、推定・動向分析

第8章エキソソーム市場：地域別、推定・動向分析

第9章競合情勢